Helix BioPharma Market Cap

Helix BioPharma has a market cap or net worth of $36.01 million as of February 27, 2025. Its market cap has increased by 3.90% in one year.

Market Cap

36.01M

Enterprise Value

35.85M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.45

Market Cap Chart

Since August 15, 1995, Helix BioPharma's market cap has increased from 6.90M to 36.01M, an increase of 422.20%. That is a compound annual growth rate of 5.75%.

Market Cap History

Date	Market Cap	% Change
Feb 27, 2025	36.01M	18.76%
Dec 31, 2024	30.32M	-11.99%
Dec 29, 2023	34.45M	8.43%
Dec 30, 2022	31.77M	-5.92%
Dec 31, 2021	33.77M	-36.31%
Dec 31, 2020	53.03M	-58.92%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	2.19B
SS Innovations International	1.66B
Nika Pharmaceuticals	1.02B
Veradigm	847.86M
Elite Pharmaceuticals	526.12M
Glass House Brands	467.63M
CytoDyn	429.88M
Northwest Biotherapeutics	352.70M

Market Cap Rankings